Altria, the maker of Marlboro and other tobacco brands, is weathering the industry's decline better than most, according to a new note from research firm Needham. The company's adjusted cigarette volumes fell 4% in the latest period, compared with a 5% drop across the U.S. market. That relative strength helped Altria lift its profit forecast for fiscal 2026, though analysts warn the following year could bring new challenges.
What's driving the outperformance?
Needham's Friday note points to Altria's ability to hold onto price-sensitive smokers. As consumers trade down to cheaper options, Altria appears to be keeping more of them in its own lineup rather than losing them to rivals or to discount brands. The company's flagship Marlboro brand gained 0.4 percentage points of share in the premium segment, reaching 60%, while its discount brand Basic added 0.3 points to 3.2%. That suggests Altria is defending its turf across both the high end and the value end of the market.
This stability gave management enough confidence to raise its fiscal 2026 adjusted earnings-per-share outlook to a range of $5.66 to $5.74, up from the previous $5.61 to $5.72. Needham's own estimate of $5.70 sits near the middle of that new range.
The 2027 speed bump
But the firm also flagged a potential problem for fiscal 2027. Year to date, Altria's reported shipments are running about 1.2 percentage points ahead of its adjusted volumes. That gap matters because shipments reflect what Altria sends into the wholesale and retail channel, while adjusted volumes are closer to what consumers actually buy.
If distributors have been building up inventory this year, they may order less later to work through those stocks. That process, known as de-stocking, can pull reported shipments down even if consumer demand stays flat. As a result, next year's comparisons could look mechanically worse unless price increases fully offset the drag.
For investors, this is a reminder that tobacco companies' reported numbers can be distorted by what's sitting in the supply chain. A company can look stronger or weaker depending on how much product is in the pipeline. When wholesalers and retailers stocked up this year, they may cut orders later, which can pressure revenue and earnings even if the customer base is holding up.
What it means for investors
Altria's story is part of a broader trend in consumer staples, where companies are trying to manage declining volumes while maintaining pricing power. The company's ability to raise its outlook despite falling volumes shows that pricing and share gains can offset some of the volume decline. But the 2027 concern highlights the limits of that strategy.
Investors tracking next year's volume comparisons will likely focus on whether the gap between shipments and adjusted volumes narrows, and how much pricing power Altria has to absorb any inventory correction. If the gap persists, it could signal that the company is relying on channel stuffing—pushing more product into the supply chain than consumers are buying—which is rarely sustainable.
Altria's situation also echoes what's happening in other consumer categories, where shoppers are trading down to cheaper options. For example, Halloween chocolate sales have dipped as consumers opt for smaller, lower-sugar treats. That same trade-down dynamic is playing out in tobacco, and Altria's ability to capture it is a key reason it's outperforming.
For everyday investors, the takeaway is that tobacco remains a cash-generative but shrinking industry. Companies like Altria are using pricing and share gains to prop up profits, but the long-term trend is still downward. The 2027 warning is a reminder that even the best-managed tobacco companies face structural headwinds, and that reported numbers can sometimes be misleading.
As always, it's worth watching how Altria manages its inventory and pricing in the coming quarters. The company's ability to navigate the 2027 challenge will be a test of whether it can continue to deliver growth in a declining market.
